Publicacións en colaboración con investigadores/as de Eli Lilly and Company (7)

2024

  1. Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe

    Endocrine, Vol. 83, Núm. 3, pp. 585-593

2017

  1. Gefitinib and EGFR gene copy number aberrations in esophageal cancer

    Journal of Clinical Oncology, Vol. 35, Núm. 20, pp. 2279-2287

2014

  1. Gefitinib for oesophageal cancer progressing after chemotherapy (COG): A phase 3, multicentre, double-blind, placebo-controlled randomised trial

    The Lancet Oncology, Vol. 15, Núm. 8, pp. 894-904

2012

  1. Mice lacking δ-opioid receptors resist the development of diet-induced obesity

    FASEB Journal, Vol. 26, Núm. 8, pp. 3483-3492

2010

  1. κ-Opioid receptors control the metabolic response to a high-energy diet in mice

    FASEB Journal, Vol. 24, Núm. 4, pp. 1151-1159

2007

  1. The central melanocortin system directly controls peripheral lipid metabolism

    Journal of Clinical Investigation, Vol. 117, Núm. 11, pp. 3475-3488

1997

  1. Leptin inhibits in vitro hypothalamic somatostatin secretion and somatostatin mRNA levels

    Endocrinology, Vol. 138, Núm. 12, pp. 5641-5644